Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7ZOZ

Crystal structure of Siglec-15 in complex with Fab

Summary for 7ZOZ
Entry DOI10.2210/pdb7zoz/pdb
DescriptorSialic acid-binding Ig-like lectin 15, Anti-Siglec 15 Fab HC, Anti-Siglec 15 Fab LC, ... (4 entities in total)
Functional Keywordssialic acid, siglec, immune system, cancer
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight81742.60
Authors
Lenza, M.P.,Oyenarte, I.,Jimenez-Barbero, J.,Ereno-Orbea, J. (deposition date: 2022-04-26, release date: 2023-06-28, Last modification date: 2024-11-20)
Primary citationLenza, M.P.,Egia-Mendikute, L.,Antonana-Vildosola, A.,Soares, C.O.,Coelho, H.,Corzana, F.,Bosch, A.,Manisha, P.,Quintana, J.I.,Oyenarte, I.,Unione, L.,Moure, M.J.,Azkargorta, M.,Atxabal, U.,Sobczak, K.,Elortza, F.,Sutherland, J.D.,Barrio, R.,Marcelo, F.,Jimenez-Barbero, J.,Palazon, A.,Ereno-Orbea, J.
Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b.
Nat Commun, 14:3496-3496, 2023
Cited by
PubMed Abstract: Sialic acid-binding Ig-like lectin 15 (Siglec-15) is an immune modulator and emerging cancer immunotherapy target. However, limited understanding of its structure and mechanism of action restrains the development of drug candidates that unleash its full therapeutic potential. In this study, we elucidate the crystal structure of Siglec-15 and its binding epitope via co-crystallization with an anti-Siglec-15 blocking antibody. Using saturation transfer-difference nuclear magnetic resonance (STD-NMR) spectroscopy and molecular dynamics simulations, we reveal Siglec-15 binding mode to α(2,3)- and α(2,6)-linked sialic acids and the cancer-associated sialyl-Tn (STn) glycoform. We demonstrate that binding of Siglec-15 to T cells, which lack STn expression, depends on the presence of α(2,3)- and α(2,6)-linked sialoglycans. Furthermore, we identify the leukocyte integrin CD11b as a Siglec-15 binding partner on human T cells. Collectively, our findings provide an integrated understanding of the structural features of Siglec-15 and emphasize glycosylation as a crucial factor in controlling T cell responses.
PubMed: 37311743
DOI: 10.1038/s41467-023-39119-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.104 Å)
Structure validation

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon